Anti cancer drugs Archives

News & Features

IDEAYA’s MAT2A Inhibitor Scores in Phase II for Urothelial and NSCLC

Malorye Branca -

July 11, 2024

News & Features

Genetic Circuits Reprogram Cancer Cells To Reduce Drug Resistance

Kevin Mayer -

July 10, 2024

3D Rendering of Antibody Drug Conjugate Molecules

News & Features

Eisai and BMS End ADC Deal, But Eisai Will Continue Development

Malorye Branca -

July 3, 2024

News & Features

Specific Exercise Shown to Reduce Chemotherapy-Induced Peripheral Neuropathy

Chris Anderson -

July 2, 2024

Human kidney cross section on scientific background

News & Features

Microbiome Pill Could Boost Kidney Cancer Responses

Malorye Branca -

July 1, 2024

Transparent tumor tomography visualising tumor microenvironment, showing vascular network in a mouse model for HER2-positive breast cancer

News & Features

Antibody-Chemo Drug Conjugate Effectively Prevents HER2-Positive Breast Cancer Recurrence

Chris Anderson -

June 28, 2024

News & Features

Moffitt Team Develops PARP Inhibitor Adaptive Therapy Approach to Ovarian Cancer

Chris Anderson -

June 27, 2024

News & Features

Compound Engineered to Combat Drug-Resistant Acute Myeloid Leukemia

Christina Jackson -

June 26, 2024

News & Features

Combination Targeted Therapy Regimen Potentially Practice-Changing for DLBCL

Laura Cowen -

June 20, 2024

News & Features

New Guideline Released for HPV-Associated Head and Neck Cancer Radiation Therapy

Chris Anderson -

June 20, 2024

123...23 Page 2 of 23

Early Metabolic Profiling Could Identify Babies at Risk of SIDS

Trainee Doctors vs. ChatGPT: Chatbot More Effective Assessing Complex Childhood Respiratory…

Insulin Resistance Linked to 31 Diseases and Early Death in Women

Study Sheds Light on How Aging Immune System Drives Cancer Development

Gastrointestinal Chemotherapy Tweak Can Reduce Side Effects

Anti cancer drugs

IDEAYA’s MAT2A Inhibitor Scores in Phase II for Urothelial and NSCLC

Genetic Circuits Reprogram Cancer Cells To Reduce Drug Resistance

Eisai and BMS End ADC Deal, But Eisai Will Continue Development

Specific Exercise Shown to Reduce Chemotherapy-Induced Peripheral Neuropathy

Microbiome Pill Could Boost Kidney Cancer Responses

Antibody-Chemo Drug Conjugate Effectively Prevents HER2-Positive Breast Cancer Recurrence

Moffitt Team Develops PARP Inhibitor Adaptive Therapy Approach to Ovarian Cancer

Compound Engineered to Combat Drug-Resistant Acute Myeloid Leukemia

Combination Targeted Therapy Regimen Potentially Practice-Changing for DLBCL

New Guideline Released for HPV-Associated Head and Neck Cancer Radiation Therapy

Related Content

Nano Delivery of Drug Combo Shrinks Pancreatic Cancer Tumors in Mice

Olaparib Monotherapy: A Promising Option for Biochemically Recurrent Prostate Cancer?

Study Details Cardiac Arrhythmia Risks of Radiation in Lung Cancer Treatment

AstraZeneca’s Durvalumab Granted Priority Review for Form of Small Cell Lung Cancer